Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. announced today that Eisai has completed the rolling submission of the Supplemental Biologics License Application (sBLA ...
Doctors say her struggle - even with the best care as a member of a prominent family - emphasises the need for more research.
Monday, November 24, 2025 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Alphabet ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback